Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1Phase 1/2 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2

Conditions

Heart Failure 3Cardiotoxicity 2Breast Neoplasms 2Thyroid cancer, medullary 1Neoplasms, Second Primary 1Carcinoma, Medullary 1Breast Diseases 1

Interventions

Echocardiography 4sacubitril and valsartan sodium hydrate drug combination 3Standard of Care 3Nutrition Assessment 3Exercise 3Electrocardiography 3Carvedilol 3dapagliflozin 2Surveys and Questionnaires 2Spironolactone 2Ivabradine 2Blood Specimen Collection 2Atorvastatin 2ziprasidone 1pertuzumab 1pegfilgrastim 1nicotinamide-beta-riboside 1empagliflozin 1candesartan 1Zolpidem 1Watchful Waiting 1Warfarin 1Vincristine 1Vecuronium Bromide 1Vascular Stiffness 1Vancomycin 1Valsartan 1Trastuzumab 1Tranexamic Acid 1Tobramycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Heart Failure × sacubitril and valsartan sodium hydrate drug combination × Clear all
NCT05194111 2026-03-13

TREAT-HF

Virginia Commonwealth University

Phase 1/2 Recruiting
53 enrolled

Heart Failure

NCT05465031 2025-03-14

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

Silesian Centre for Heart Diseases

Phase 4 Recruiting
600 enrolled
Breast

Breast Diseases, Breast Neoplasms, Heart Failure, Neoplasms, Second Primary, Cardiotoxicity

NCT03760588 2025-02-12

PRADAII

University Hospital, Akershus

Phase 2 Completed
138 enrolled
Breast

Breast Neoplasms, Heart Failure

Data powered by HemOnc (CC BY 4.0) Colophon âš¡